A citation-based method for searching scientific literature

Stephen Kaptoge, Emanuele Di Angelantonio, Gordon Lowe, Mark B Pepys, Simon G Thompson, Rory Collins, John Danesh. Lancet 2010
Times Cited: 1508







List of co-cited articles
377 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
26

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
872
17

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
15

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Thomas A Pearson, George A Mensah, R Wayne Alexander, Jeffrey L Anderson, Richard O Cannon, Michael Criqui, Yazid Y Fadl, Stephen P Fortmann, Yuling Hong, Gary L Myers,[...]. Circulation 2003
13

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
12

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
550
10

Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
419
10

Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
479
9

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Yiran Guo, Christina Chung, Anne Peasey, Roman Pfister,[...]. Lancet 2012
644
8

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Paul M Ridker, Peter Libby, Jean G MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M Everett, Robert J Glynn. Eur Heart J 2018
231
8

Inflammation in atherosclerosis.
Peter Libby. Arterioscler Thromb Vasc Biol 2012
8


Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Erin A Bohula, Robert P Giugliano, Christopher P Cannon, Jing Zhou, Sabina A Murphy, Jennifer A White, Andrew M Tershakovec, Michael A Blazing, Eugene Braunwald. Circulation 2015
191
7


Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.
Kristiina Rajamäki, Jani Lappalainen, Katariina Oörni, Elina Välimäki, Sampsa Matikainen, Petri T Kovanen, Kari K Eklund. PLoS One 2010
600
6



C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
6


Chronic inflammation in the etiology of disease across the life span.
David Furman, Judith Campisi, Eric Verdin, Pedro Carrera-Bastos, Sasha Targ, Claudio Franceschi, Luigi Ferrucci, Derek W Gilroy, Alessio Fasano, Gary W Miller,[...]. Nat Med 2019
765
6

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.
Renata Micha, Fumiaki Imamura, Moritz Wyler von Ballmoos, Daniel H Solomon, Miguel A Hernán, Paul M Ridker, Dariush Mozaffarian. Am J Cardiol 2011
338
5

Inflammation and atherosclerosis.
Peter Libby, Paul M Ridker, Attilio Maseri. Circulation 2002
5

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.
Frances Wensley, Pei Gao, Stephen Burgess, Stephen Kaptoge, Emanuele Di Angelantonio, Tina Shah, James C Engert, Robert Clarke, George Davey-Smith, Børge G Nordestgaard,[...]. BMJ 2011
436
5

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
5

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
5

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.
Peter Libby, Joseph Loscalzo, Paul M Ridker, Michael E Farkouh, Priscilla Y Hsue, Valentin Fuster, Ahmed A Hasan, Salomon Amar. J Am Coll Cardiol 2018
245
5

Progress and challenges in translating the biology of atherosclerosis.
Peter Libby, Paul M Ridker, Göran K Hansson. Nature 2011
5

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.
Stephen Kaptoge, Sreenivasa Rao Kondapally Seshasai, Pei Gao, Daniel F Freitag, Adam S Butterworth, Anders Borglykke, Emanuele Di Angelantonio, Vilmundur Gudnason, Ann Rumley, Gordon D O Lowe,[...]. Eur Heart J 2014
342
5

Anti-inflammatory approaches to ischaemic stroke prevention.
Peter J Kelly, Sean Murphy, Sarah Coveney, Francisco Purroy, Robin Lemmens, Georgios Tsivgoulis, Chris Price. J Neurol Neurosurg Psychiatry 2018
34
14

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Paul M Ridker, Matt Devalaraja, Florian M M Baeres, Mads D M Engelmann, G Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo Pergola, Dominic Raj,[...]. Lancet 2021
65
7

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, Mary Ann Lukas, Elizabeth Tarka, P Gabriel Steg, Judith S Hochman, Christoph Bode, Aldo P Maggioni, KyungAh Im,[...]. JAMA 2014
292
4

Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Yunwei Li, Xiaoming Zhong, Guanchang Cheng, Cuihua Zhao, Lei Zhang, Yan Hong, Qilin Wan, Ruili He, Zhizhong Wang. Atherosclerosis 2017
162
4

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
Emelia J Benjamin, Paul Muntner, Alvaro Alonso, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Sandeep R Das,[...]. Circulation 2019
4

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
4

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
4

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy.
Tjerk S J Opstal, Renate M Hoogeveen, Aernoud T L Fiolet, Max J M Silvis, Salem H K The, Willem A Bax, Dominique P V de Kleijn, Arend Mosterd, Erik S G Stroes, Jan H Cornel. Circulation 2020
50
8

Colchicine--Update on mechanisms of action and therapeutic uses.
Ying Ying Leung, Laura Li Yao Hui, Virginia B Kraus. Semin Arthritis Rheum 2015
330
4

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
John Danesh, Stephen Kaptoge, Andrea G Mann, Nadeem Sarwar, Angela Wood, Sara B Angleman, Frances Wensley, Julian P T Higgins, Lucy Lennon, Gudny Eiriksdottir,[...]. PLoS Med 2008
496
4

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
John Danesh, Jeremy G Wheeler, Gideon M Hirschfield, Shinichi Eda, Gudny Eiriksdottir, Ann Rumley, Gordon D O Lowe, Mark B Pepys, Vilmundur Gudnason. N Engl J Med 2004
4

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
4



High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
Omair Yousuf, Bibhu D Mohanty, Seth S Martin, Parag H Joshi, Michael J Blaha, Khurram Nasir, Roger S Blumenthal, Matthew J Budoff. J Am Coll Cardiol 2013
293
4



Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
Alexander Thompson, Pei Gao, Lia Orfei, Sarah Watson, Emanuele Di Angelantonio, Stephen Kaptoge, Christie Ballantyne, Christopher P Cannon, Michael Criqui, Mary Cushman,[...]. Lancet 2010
466
3


Immune and inflammatory mechanisms of atherosclerosis (*).
Elena Galkina, Klaus Ley. Annu Rev Immunol 2009
978
3

Darapladib for preventing ischemic events in stable coronary heart disease.
Harvey D White, Claes Held, Ralph Stewart, Elizabeth Tarka, Rebekkah Brown, Richard Y Davies, Andrzej Budaj, Robert A Harrington, P Gabriel Steg, Diego Ardissino,[...]. N Engl J Med 2014
358
3



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.